Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
T Stamp A | IDAI | Apr 30, 2024 | 0.77 | -1.49 |
T-Mobile US | TMUS | Apr 30, 2024 | 164.17 | -0.05 |
T. Rowe Price Blue Chip Growth ETF | TCHP | Apr 30, 2024 | 33.95 | -1.65 |
T. Rowe Price Dividend Growth ETF | TDVG | Apr 30, 2024 | 36.78 | -1.04 |
T. Rowe Price Equity Income ETF | TEQI | Apr 30, 2024 | 38.61 | -0.89 |
T. Rowe Price Group | TROW | Apr 30, 2024 | 109.57 | -2.24 |
T. Rowe Price Growth Stock ETF | TGRW | Apr 30, 2024 | 32.80 | -1.69 |
T2 Biosystems | TTOO | Apr 30, 2024 | 3.36 | +14.12 |
Taboola.com | TBLA | Apr 30, 2024 | 4.20 | -1.18 |
Tactile Systems Technology | TCMD | Apr 30, 2024 | 13.77 | -2.55 |
Taitron Components A | TAIT | Apr 30, 2024 | 3.15 | -1.25 |
Taiwan Fund | TWN | Apr 30, 2024 | 38.75 | -0.90 |
Taiwan Index MSCI Ishares | EWT | Apr 30, 2024 | 47.16 | -1.57 |
Taiwan Semiconductor Manufacturing ADR | TSM | Apr 30, 2024 | 137.34 | -0.84 |
Take-Two Interactive Software | TTWO | Apr 30, 2024 | 142.81 | -1.01 |
Takeda Pharmaceutical ADR | TAK | Apr 30, 2024 | 13.08 | -0.68 |
TAL Education Group ADR | TAL | Apr 30, 2024 | 12.04 | -4.90 |
Talis Biomedical | TLIS | Apr 30, 2024 | 8.62 | -4.96 |
Talkspace | TALK | Apr 30, 2024 | 3.06 | -0.97 |
Talos Energy | TALO | Apr 30, 2024 | 13.18 | -5.99 |
Talphera | TLPH | Apr 30, 2024 | 1.03 | 0.00 |
Tandem Diabetes Care | TNDM | Apr 30, 2024 | 36.69 | -0.97 |
Tanger | SKT | Apr 30, 2024 | 28.35 | -0.91 |
Tango Therapeutics | TNGX | Apr 30, 2024 | 7.70 | -2.16 |
Tantech | TANH | Apr 30, 2024 | 0.57 | +0.53 |
Taoping | TAOP | Apr 30, 2024 | 1.02 | +2.00 |
Tapestry | TPR | Apr 30, 2024 | 39.92 | -2.59 |
Targa Resources | TRGP | Apr 30, 2024 | 114.06 | -2.68 |
Target | TGT | Apr 30, 2024 | 160.98 | -1.68 |
Target Global Acquisition I A | TGAA | Apr 30, 2024 | 11.29 | +0.53 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.